Cargando…

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a devastating and fatal chronic lung disease. While current pharmacotherapies have improved patient quality of life, PAH drugs suffer from limitations in the form of short-term pharmacokinetics, instability, and poor organ specificity. Traditionally, nanotech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Segura-Ibarra, Victor, Wu, Suhong, Hassan, Nida, Moran-Guerrero, Jose A., Ferrari, Mauro, Guha, Ashrith, Karmouty-Quintana, Harry, Blanco, Elvin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055049/ https://www.ncbi.nlm.nih.gov/pubmed/30061840 http://dx.doi.org/10.3389/fphys.2018.00890

Ejemplares similares

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
por: Karmouty-Quintana, Harry, et al.
Publicado: (2018)

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension
por: Mertens, Tinne C. J., et al.
Publicado: (2018)

Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
por: Collum, Scott D., et al.
Publicado: (2017)

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021)

Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
por: Sarah, Beshay, et al.
Publicado: (2021)

Drs. Sandeep Sahay and Ashrith Guha Lead Issue on Pulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

SARS–CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights
por: VasanthiDharmalingam, Prakash, et al.
Publicado: (2021)

Snakes and Ladders: A Potential Therapy of Hepatocyte Growth Factor and Pigment Epithelium-derived Factor in Pulmonary Hypertension
por: Zambelas, Joseph M., et al.
Publicado: (2023)

Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
por: Revercomb, Lucy, et al.
Publicado: (2021)

MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
por: Carregal-Romero, Susana, et al.
Publicado: (2020)

Organelle Transplantation: Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration (Adv. Sci. 3/2018)
por: Wu, Suhong, et al.
Publicado: (2018)

Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration
por: Wu, Suhong, et al.
Publicado: (2018)

Management of pulmonary hypertension associated with valvular heart disease with angiotensin‐receptor neprilysin inhibitor
por: Ali, Hyeon‐Ju Ryoo, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension: Iron Matters
por: Ramakrishnan, Latha, et al.
Publicado: (2018)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension
por: Forouzan, Omid, et al.
Publicado: (2019)

E‐REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
por: Sahay, Sandeep, et al.
Publicado: (2022)

Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension
por: Grignola, Juan C., et al.
Publicado: (2021)

Effects of voluntary running on the skeletal muscle of rats with pulmonary artery hypertension
por: Drummond, Filipe Rios, et al.
Publicado: (2023)

Skeletal muscle dysfunctions in pulmonary arterial hypertension: Effects of aerobic exercise training
por: Drummond, Filipe Rios, et al.
Publicado: (2023)

Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?
por: Li, Ke-Xue, et al.
Publicado: (2022)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology
por: Lee, Michael H., et al.
Publicado: (2022)

Epsin15 Homology Domains: Role in the Pathogenesis of Pulmonary Arterial Hypertension
por: Predescu, Dan, et al.
Publicado: (2018)

Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension
por: Sharifi Kia, Danial, et al.
Publicado: (2021)

Data-driven computational models of ventricular-arterial hemodynamics in pediatric pulmonary arterial hypertension
por: Tossas-Betancourt, Christopher, et al.
Publicado: (2022)

Editorial: Calcium and pulmonary hypertension
por: Li, Ji-Feng, et al.
Publicado: (2022)

NS5806 Induces Electromechanically Discordant Alternans and Arrhythmogenic Voltage-Calcium Dynamics in the Isolated Intact Rabbit Heart
por: Wang, Sufen, et al.
Publicado: (2019)

New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension
por: Hu, Liqing, et al.
Publicado: (2020)

Piezo1, a novel therapeutic target to treat pulmonary arterial hypertension
por: Yang, Qifeng, et al.
Publicado: (2023)

Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
por: Foris, Vasile, et al.
Publicado: (2023)

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension
por: Hinton, Martha, et al.
Publicado: (2023)

Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension
por: Goel, Khushboo, et al.
Publicado: (2022)

The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
por: Lo, Charmaine C. W., et al.
Publicado: (2018)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis
por: Kanvinde, Shrey, et al.
Publicado: (2023)

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy
por: Kai, Megumi, et al.
Publicado: (2019)

Left-Ventricular Energetics in Pulmonary Arterial Hypertension-Induced Right-Ventricular Hypertrophic Failure
por: Han, June-Chiew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ctlk68vkgc8g42cbi4napssk09